<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="and colleagues is that all individuals with symptomatic infection with" exact="severe acute respiratory syndrome" post="(SARS) coronavirus 2 (SARS-CoV-2) are eventually tested and reported."/>
 <result pre="drug, hydroxychloroquine, is licensed for the chemoprophylaxis and treatment of" exact="malaria" post="and as a disease-modifying antirheumatic drug. It has a"/>
 <result pre="ameliorate viral shedding.5 Clinical trials of hydroxychloroquine treatment for COVID-19" exact="pneumonia" post="are underway in China (NCT04261517 and NCT04307693). We are"/>
 <result pre="close contactsmedRxiv2020published online March 4.10.1101/2020.03.03.20028423(preprint). 3WelliverRMontoASCarewiczOEffectiveness of oseltamivir in preventing" exact="influenza" post="in household contacts: a randomized controlled trialJAMA285200174875411176912 4YaoXYeFZhangMIn vitro"/>
 <result pre="of optimized dosing design of hydroxychloroquine for the treatment of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020published online March 9.10.1093/cid/ciaa237 5TettSECutlerDJDayROBrownKFBioavailability"/>
</results>
